title: Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Perú.
abstract: We describe 11 patients with massive brain infection with viable cysticerci, undetectable inflammatory reaction on CNS imaging, and an unexpectedly high (82%) prevalence of tapeworm infection. With the exception of two individuals with heavy parasite loads, patients had a relatively benign clinical course and tolerated the use of cysticidal drugs. This group of patients represents a particular presentation of neurocysticercosis, different from the previously described syndromes of cysticercotic encephalitis and disseminated systemic cysticercosis.
authors.affiliation: Department of Microbiology, Universidad Peruana Cayetano Heredia, Lima, Perú. hgarcia@pol.com.pe
authors.forename: H H
authors.initials: HH
authors.lastname: García
authors.forename: O H
authors.initials: OH
authors.lastname: Del Brutto
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D015766:Albendazole / Q000627:therapeutic use; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use; D001927:Brain Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000469:parasitology*; D002353:Carrier State; D002648:Child; D003551:Cysticercosis / Q000150:complications / Q000453:epidemiology; D003552:Cysticercus / Q000302:isolation & purification; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D020019:Neurocysticercosis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000469:parasitology*; D011223:Praziquantel / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D000871:Anthelmintics; D011223:Praziquantel; D015766:Albendazole